A discrete choice experiment to investigate patient preferences for HIV testing programs in Bogotá, Colombia

Ben F.M. Wijnen, Ruben P.L.B. Van Engelen, Jan Ostermann, Axel Muhlbacher, Arnolf F.W. Hendriks, Rafael Conde, Javier G.R. Gonzalez, Mark J.G. Govers, Silvia M.A.A. Evers, Mickaël Hiligsmann

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: To assess patients’ preferences for HIV testing in Colombia. Methods: A discrete choice experiment was used to assess preferences of patients diagnosed with HIV, for HIV testing in two HIV clinics in Bogotá, Colombia. Patients were asked to choose repeatedly between two hypothetical HIV testing options that varied with respect to five attributes: distance to testing site, confidentiality, testing days, sample collection method, and the services if HIV positive. A random parameter model was used to analyze the data. Results: A total of 249 questionnaires were eligible for data analysis. Respondents showed a preference for testing on weekdays, nobody being aware, a sample taken from the arm, and receiving medications through a referral. The respondents showed a high negative preference for many people being aware, followed by testing during the weekend and home testing. Subgroup analyses by gender and prior testing history did not reveal significant differences. Conclusion: This study suggests that patients’ preferences for HIV testing focused especially on confidentiality, availability during weekdays, and using a sample from the arm. This information could be useful to improve uptake of HIV testing in Bogotá, Colombia.

Original languageEnglish (US)
Pages (from-to)195-201
Number of pages7
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume19
Issue number2
DOIs
StatePublished - Mar 4 2019

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'A discrete choice experiment to investigate patient preferences for HIV testing programs in Bogotá, Colombia'. Together they form a unique fingerprint.

Cite this